MCM3AP and neoplasm: At present, a reliable evaluation index for the prognosis of tumor diseases is lacking, but the application of MCM3AP-AS1 can greatly improve the ability of clinicians to evaluate CRC, intervene in time, and provide a more reliable guarantee for the prognosis of patients.